| 2025 | 2024 | |||
|---|---|---|---|---|
| Gross margin | 2,0 M € | +192.3% | 678,9 k € | |
| EBITDA | 148,4 k € | +259.7% | 41,3 k € | |
| Operating profit | 148,4 k € | +259.7% | 41,3 k € | |
| Profit/loss | 85,2 k € | +207.1% | 27,7 k € | |
| Equity | 129,4 k € | +192.6% | 44,2 k € | |
| Total assets | 1,2 M € | +149.4% | 495,4 k € | |
| Cash | 387,6 k € | +165.8% | 145,8 k € | |
| Debts | 995,2 k € | +154.6% | 390,9 k € | |
| Staff | 9 | 4,7 | ||
Private limited company · Machelen (Brab.) · incorporated on 03/05/2023 · 9,0 ETP
Private limited company profitable and well capitalised. Cash position rising (+165.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
BIOCON BIOLOGICS BELGIUM is a Private limited company incorporated in 2023. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Machelen (Brab.). It employs on average 9,0 ETP workers (FTE).